Reports

The global Direct Compressible Excipients market was valued at 10541 million in 2024 and is projected to reach US$ 16088 million by 2031, at a CAGR of 6.4% during the forecast period.

The global Heavy Metal Detoxification Drug market was valued at 84.93 million in 2024 and is projected to reach US$ 156 million by 2031, at a CAGR of 9.2% during the forecast period.

The global Repurposed Human Immunosuppressants market was valued at 660 million in 2024 and is projected to reach US$ 995 million by 2031, at a CAGR of 5.6% during the forecast period.

The global Self-administered Biologics for Metabolic & Endocrine Disorders market was valued at 62564 million in 2024 and is projected to reach US$ 88872 million by 2031, at a CAGR of 5.3% during the forecast period.

The global Obesity-Diabetes Drug market was valued at 54189 million in 2024 and is projected to reach US$ 93610 million by 2031, at a CAGR of 8.1% during the forecast period.

The global Cell Culture Freezing Storage Agents market was valued at 685 million in 2024 and is projected to reach US$ 1249 million by 2031, at a CAGR of 9.7% during the forecast period.

The global Vitamin K–Dependent Coagulation Factor Complex market was valued at 1209 million in 2024 and is projected to reach US$ 2537 million by 2031, at a CAGR of 11.2% during the forecast period.

The global Plant Derived Analgesics market was valued at 1970 million in 2024 and is projected to reach US$ 3144 million by 2031, at a CAGR of 7.1% during the forecast period.

The global Bone Meal Supplement market was valued at 768 million in 2024 and is projected to reach US$ 1065 million by 2031, at a CAGR of 4.9% during the forecast period.

The global PCC Therapy market was valued at 1209 million in 2024 and is projected to reach US$ 2537 million by 2031, at a CAGR of 11.2% during the forecast period.